Access Conditions DEA State Laws 
Cannabis Law Report
OCTOBER 4, 2021
A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.
The Joint Blog
JUNE 4, 2021
Schedule I drugs like heroin, Lysergic Acid Diethylamide (LSD), and ecstasy are strictly regulated by the Federal Government but Marijuana has be made an exception in some states. Marijuana is also classified as a Schedule I drug but it has been given the approval for medical and recreational at some state levels.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
MARCH 4, 2020
The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either. Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.
Cannabis Law Report
JULY 23, 2021
Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). Decriminalization of Cannabis, Recognition of State law Controlling Cannabis. It would transfer primary agency jurisdiction over cannabis from the DEA to the FDA, TTB, and ATF.
CannaMD
SEPTEMBER 15, 2020
MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. SHORT ANSWER: Full-time and seasonal Florida residents who suffer from an eligible medical condition. ” Translation?
Canna Law Blog
NOVEMBER 16, 2021
And a safe harbor is in place for pretty much all interstate commercial cannabis activity after passage of the bill and until the Secretary promulgates all final regulations under the SRA (of course, that commercial cannabis activity must still be in line with applicable state cannabis regulations). The enforcement role moves from DEA to ATF.
Canna Law Blog
MARCH 4, 2020
The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either. Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.
Expert insights. Personalized for you.
52 
Let's personalize your content